Evaluation of the use of Tru-Cut Needle Biopsy in the Diagnosis of Chest Wall Tumors
International Journal of Cardiovascular and Thoracic Surgery
Volume 1, Issue 1, July 2015, Pages: 5-8
Received: Jun. 4, 2015; Accepted: Jun. 30, 2015; Published: Jul. 1, 2015
Views 2319      Downloads 85
Authors
Walid Abu Arab, Cardiothoracic Surgery Department, Faculty of Medicine, University of Alexandria, Alexandria, Egypt; Service of Thoracic Surgery, University of Sherbrooke, Quebec, Canada
Akram Allam, Cardiothoracic Surgery Department, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
Khaled Karara, Cardiothoracic Surgery Department, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
Article Tools
Follow on us
Abstract
Introduction: Chest wall tumors can be either primary, metastatic or radiation induced. Moreover, it can be due to involvement by lung or breast cancer. Although clinical and radiological assessments are important in evaluation of patients with chest wall tumors; the histo-pathological diagnosis remains the most important factor in determining the appropriate management. One of the methods to get tissue biopsy is tru-cut needle biopsy. Aim: This study aimed to determine the efficacy and complications of the use of tru-cut needle biopsy in diagnosis of chest wall tumors. Patients and methods: This is a retrospective study in which the files of patients who underwent tru-cut needle biopsy at cardiothoracic surgery department of Alexandria University were reviewed. Results: Twenty patients (13 males and 7 females) underwent tru-cut needle biopsy for chest wall tumors during the period between January 2003 and December 2008. Age ranged between 17 to 75 years (52.4 ± 13.7 years old). Ninety-five percent of patients were presented with chest wall swelling either alone or with pain. All patients except one had tru-cut needle biopsy without radiological assist. Tru-cut needle biopsy was performed with the aid of fluoroscopy in one patient. Pre-operative tissue diagnosis could be established with accuracy in 90% of patients. In 90% of patients, tru-cut needle biopsy was able to determine if the lesion is benign or malignant while in two patients it was inconclusive. No complications were encountered during or following the procedure. Moreover, no recurrence at the site of biopsy was detected during 3 years follow-up. Conclusion: Tru-cut needle biopsy; with or without radiological assist; is of utmost help in accurate pre-operative histo-pathological diagnosis with minimal complications. Accuracy in determination of diagnosis depends on the skills of the personnel who perform the biopsy and the pathologist. Recurrence at site of the biopsy is rare.
Keywords
Tru-Cut Biopsy, Needle Biopsy, Chest Wall Tumors
To cite this article
Walid Abu Arab, Akram Allam, Khaled Karara, Evaluation of the use of Tru-Cut Needle Biopsy in the Diagnosis of Chest Wall Tumors, International Journal of Cardiovascular and Thoracic Surgery. Vol. 1, No. 1, 2015, pp. 5-8. doi: 10.11648/j.ijcts.20150101.12
References
[1]
Bnjamin O, Anderson MD, Michael EB. Chest wall neoplasms and their management. Ann Thorac Surg 1994; 58: 1774-81.
[2]
Constantaine P. Karakousis: Chest wall tumors In: Hatch L. Karamanoukian, Paulo R. Soltoski, Tomas A. Salerno: `Thoracic Surgery Secrets`1st edd, Hanley & Belfus Inc., 2001; 15 edd pp 657.
[3]
Jakanani GC, Saifuddin A. Percutaneous image-guided needle biopsy of rib lesions: a retrospective study of diagnostic outcome in 51 cases. Skeletal radiology.42 (1):85-90.
[4]
Datir A, Pechon P, Saifuddin A. Imaging-guided percutaneous biopsy of pathologic fractures: a retrospective analysis of 129 cases. American Journal of Roentgenology. 2009; 193(2):504-8.
[5]
Hau M, Kim J, Kattapuram S, Hornicek FJ, Rosenberg AE, Gebhardt MC, et al. Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Skeletal radiology. 2002; 31(6):349-53.
[6]
Welker JA, Henshaw RM, Jelinek J, Shmookler BM, Malawer MM. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer. 2000; 89(12):2677-86.
[7]
Douglas Mathisen, Richard I. White: `Primary chest wall neoplasms`In Oxford text book of Surgery, 2000; 15 edd, PP657.
[8]
M Bernadette Rayan, Marion J, Mc Murtrey, and Jack A Roth `Current management of chest wall tumors`Surg Clin North America 1989; 69 (5): 1061-80.
[9]
Matsumoto K, Ashizawa K, Tagawa T, Nagayasu T. Chest wall implantation of thymic cancer after computed tomography-guided core needle biopsy. European journal of cardio-thoracic surgery. 2007; 32(1):171-3.
[10]
Loubeyre P, Copercini M, Dietrich P-Y. Percutaneous CT-guided multisampling core needle biopsy of thoracic lesions. American Journal of Roentgenology. 2005; 185(5):1294-8.
[11]
Klein JS, Salomon G, Stewart EA. Transthoracic needle biopsy with a coaxially placed 20-gauge automated cutting needle: results in 122 patients. Radiology. 1996;198(3):715-20.
[12]
Westcott JL, Rao N, Colley DP. Transthoracic needle biopsy of small pulmonary nodules. Radiology. 1997;202(1):97-103.
[13]
Cox JE, Chiles C, McManus CM, Aquino SL, Choplin RH. Transthoracic Needle Aspiration Biopsy: Variables That Affect Risk of Pneumothorax1. Radiology. 1999; 212(1):165-8.
[14]
Omura MC, Motamedi K, UyBico S, Nelson SD, Seeger LL. Revisiting CT-guided percutaneous core needle biopsy of musculoskeletal lesions: contributors to biopsy success. American Journal of Roentgenology.197 (2):457-61.
[15]
Kattach H, Hasan S, Clelland C, Pillai R. Seeding of stage I thymoma into the chest wall 12 years after needle biopsy. The Annals of thoracic surgery. 2005; 79(1):323-4.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186